Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions

Department of Surgery, Division of Acute Care Surgery, University of Florida, Gainesville, FL, USA.
American journal of surgery (Impact Factor: 2.36). 02/2011; 202(2):127-32. DOI: 10.1016/j.amjsurg.2010.09.005
Source: PubMed

ABSTRACT Percutaneous needle biopsy, also known as minimally invasive breast biopsy (MIBB), has become the gold standard for the initial assessment of suspicious breast lesions. The purpose of this study is to determine modern rates of MIBB and open breast biopsy.
The Florida Agency for Health Care Administration outpatient surgery and procedure database was queried for patients undergoing open surgical biopsy and MIBB between 2003 and 2008.
Although there was an increase in the use of MIBB, the overall rate of open surgical biopsy remained high (∼30%). A reduction in the open biopsy rate from 30% to 10% could be associated with a charge reduction of >$37.2 million per year.
The current rate of open surgical breast biopsy remains high. Interventions and quality initiatives are warranted, which could lead to a reduction in unnecessary operations for women, improved patient care, and a reduction in breast health care costs.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose Use of needle biopsy is a proposed quality measure in the diagnosis and treatment of breast cancer, yet prior literature documents underuse. Nationally, little is known regarding the contribution of a patient's surgeon to needle biopsy use, and knowledge regarding downstream impact of needle biopsy on breast cancer care is incomplete. Methods Using 2003 to 2007 nationwide Medicare data from 89,712 patients with breast cancer and 12,405 surgeons, logistic regression evaluated the following three outcomes: surgeon consultation before versus after biopsy, use of needle biopsy (yes or no), and number of surgeries for cancer treatment. Multilevel analyses were adjusted for physician, patient, and structural covariates. Results Needle biopsy was used in 68.4% (n = 61,353) of all patients and only 53.7% of patients seen by a surgeon before biopsy (n = 32,953/61,312). Patient factors associated with surgeon consultation before biopsy included Medicaid coverage, rural residence, residence more than 8.1 miles from a radiologic facility performing needle biopsy, and no mammogram within 60 days before consultation. Among patients with surgeon consultation before biopsy, surgeon factors such as absence of board certification, training outside the United States, low case volume, earlier decade of medical school graduation, and lack of specialization in surgical oncology were negatively correlated with receipt of needle biopsy. Risk of multiple cancer surgeries was 33.7% for patients undergoing needle biopsy compared with 69.6% for those who did not (adjusted relative risk, 2.08; P < .001). Conclusion Needle biopsy is underused in the United States, resulting in a negative impact on breast cancer diagnosis and treatment. Surgeon-level interventions may improve needle biopsy rates and, accordingly, quality of care.
    Journal of Clinical Oncology 06/2014; 32(21). DOI:10.1200/JCO.2013.52.8257 · 17.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We present results from a recent study involving the ImagioTM breast imaging system, which produces fused real-time two-dimensional color-coded opto-acoustic (OA) images that are co-registered and temporally inter- leaved with real-time gray scale ultrasound using a specialized duplex handheld probe. The use of dual optical wavelengths provides functional blood map images of breast tissue and tumors displayed with high contrast based on total hemoglobin and oxygen saturation of the blood. This provides functional diagnostic information pertaining to tumor metabolism. OA also shows morphologic information about tumor neo-vascularity that is complementary to the morphological information obtained with conventional gray scale ultrasound. This fusion technology conveniently enables real-time analysis of the functional opto-acoustic features of lesions detected by readers familiar with anatomical gray scale ultrasound. We demonstrate co-registered opto-acoustic and ultrasonic images of malignant and benign tumors from a recent clinical study that provide new insight into the function of tumors in-vivo. Results from the Feasibility Study show preliminary evidence that the technology may have the capability to improve characterization of benign and malignant breast masses over conventional diagnostic breast ultrasound alone and to improve overall accuracy of breast mass diagnosis. In particular, OA improved speci city over that of conventional diagnostic ultrasound, which could potentially reduce the number of negative biopsies performed without missing cancers.
    Proceedings of SPIE - The International Society for Optical Engineering 02/2014; DOI:10.1117/12.2043050 · 0.20 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Minimally invasive breast biopsy (MIBB) is recommended biopsy method for suspicious lesions. This study examines national trends and factors associated with utilization of open breast biopsy (OBB). Methods The national inpatient sample database was used to examine trends and factors associated with the utilization of OBB. Factors associated with OBB was evaluated using chi-square for univariate and logistic regression for multivariate analysis. Results OBB rate was 34%. Patients <50 had OBB rates of 47% while those >50 years of age (29.1%, p<0.001). Higher OBB rates were observed in Asian (39.8%) and Hispanic (40.6%) compared to white women (34.1% p < 0.001). Private insurance patients were more likely to have OBB compared to Medicaid/Medicare patients (40.9% vs 30.6% p<0.001). 1.2% of women who underwent OBB required multiple biopsies for diagnosis compared to 0.5% for MIBB (P<0.001). Conclusions OBB is still performed in 1/3 of women despite higher morbidity and less accuracy. Factors associated with higher OBB rate included: younger age, Asian ethnicity, private insurance, Small, rural and non-teaching hospitals.
    The American Journal of Surgery 09/2014; DOI:10.1016/j.amjsurg.2014.02.008 · 2.41 Impact Factor

Full-text (2 Sources)

Available from
May 22, 2014